Those results were confirmed in two patients who responded well to FGFR inhibition therapy and had FGFR1amp tumor overexpressing MYC.17 The authors proposed that the pro-apoptotic activity of MYC was necessary to facilitate FGFR inhibitor-induced cell death. Here, MYC is linked to neoplasm.